Co-Author
This page shows the publications co-authored by John Stone and Hyon Choi.
Connection Strength
4.137
-
Derivation and Validation of Algorithms to Identify Patients With Immunoglobulin-G4-Related Disease Using Administrative Claims Data. ACR Open Rheumatol. 2022 Apr; 4(4):371-377.
Score: 0.246
-
The Effects of Treatment on Body Mass Index in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial. Rheumatol Ther. 2022 Apr; 9(2):497-508.
Score: 0.244
-
ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry. J Rheumatol. 2021 07; 48(7):1060-1064.
Score: 0.230
-
All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. Rheumatology (Oxford). 2020 09 01; 59(9):2308-2315.
Score: 0.223
-
Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2019 11; 71(11):1879-1887.
Score: 0.209
-
Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis. Ann Rheum Dis. 2020 04; 79(4):e40.
Score: 0.200
-
An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index. Arthritis Care Res (Hoboken). 2018 11; 70(11):1671-1678.
Score: 0.196
-
Improving Mortality in End-Stage Renal Disease Due to Granulomatosis With Polyangiitis (Wegener's) From 1995 to 2014: Data From the United States Renal Data System. Arthritis Care Res (Hoboken). 2018 10; 70(10):1495-1500.
Score: 0.194
-
Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System. Ann Rheum Dis. 2018 09; 77(9):1333-1338.
Score: 0.190
-
Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2017 07; 69(7):1004-1010.
Score: 0.179
-
Nationwide Trends in Hospitalizations and In-Hospital Mortality in Granulomatosis With Polyangiitis (Wegener's). Arthritis Care Res (Hoboken). 2017 06; 69(6):915-921.
Score: 0.177
-
Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis. Arthritis Rheumatol. 2017 01; 69(1):176-184.
Score: 0.173
-
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets. Arthritis Rheumatol. 2016 12; 68(12):2945-2952.
Score: 0.172
-
Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol. 2016 09; 68(9):2283-9.
Score: 0.169
-
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis. Ann Rheum Dis. 2017 Mar; 76(3):543-546.
Score: 0.168
-
Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford). 2016 Jun; 55(6):1000-8.
Score: 0.163
-
Improved survival in granulomatosis with polyangiitis: A general population-based study. Semin Arthritis Rheum. 2016 Feb; 45(4):483-9.
Score: 0.157
-
The Association of Illness-Related Uncertainty with Mental Health in Systemic Autoimmune Rheumatic Diseases. J Rheumatol. 2022 Apr 01.
Score: 0.062
-
The association of smoking with immunoglobulin G4-related disease: a case-control study. Rheumatology (Oxford). 2021 11 03; 60(11):5310-5317.
Score: 0.060
-
Validation of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis as the Cause of End-Stage Renal Disease in the US Renal Data System. ACR Open Rheumatol. 2022 Jan; 4(1):8-12.
Score: 0.060
-
Association of renal transplantation with reduced risk of myocardial infarction and ischemic stroke in ANCA-associated vasculitis: An observational cohort study. Semin Arthritis Rheum. 2021 12; 51(6):1180-1185.
Score: 0.060
-
Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic. ACR Open Rheumatol. 2021 Dec; 3(12):834-841.
Score: 0.060
-
Topic modeling to characterize the natural history of ANCA-Associated vasculitis from clinical notes: A proof of concept study. Semin Arthritis Rheum. 2021 02; 51(1):150-157.
Score: 0.057
-
Lifetime Allergy Symptoms in IgG4-Related Disease: A Case-Control Study. Arthritis Care Res (Hoboken). 2020 Dec 20.
Score: 0.057
-
Treatment Delays Associated With Prior Authorization for Infusible Medications: A Cohort Study. Arthritis Care Res (Hoboken). 2020 11; 72(11):1543-1549.
Score: 0.056
-
Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. JAMA Intern Med. 2020 06 01; 180(6):870-876.
Score: 0.055
-
Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis. ACR Open Rheumatol. 2020 May; 2(5):261-268.
Score: 0.054
-
Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race. Ann Allergy Asthma Immunol. 2020 08; 125(2):190-195.e2.
Score: 0.054
-
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020 01; 79(1):77-87.
Score: 0.053
-
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020 01; 72(1):7-19.
Score: 0.053
-
Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019 03; 78(3):406-412.
Score: 0.050
-
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Ann Rheum Dis. 2016 Jun; 75(6):1166-9.
Score: 0.040
-
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002 May; 46(5):1309-18.
Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.